Dynavax Technologies
DVAX
#5481
Rank
โ‚น116.04 B
Marketcap
โ‚น988.21
Share price
0.23%
Change (1 day)
-9.49%
Change (1 year)

Dynavax Technologies (DVAX) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น85.14 Billion

According to Dynavax Technologies 's latest financial reports the company's total assets are โ‚น85.14 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Dynavax Technologies - Total assets on balance sheet (from 2003 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น84.60 B1.93%
2023-12-31โ‚น83.00 B1.75%
2022-12-31โ‚น81.57 B5.46%
2021-12-31โ‚น77.35 B199.4%
2020-12-31โ‚น25.83 B29.83%
2019-12-31โ‚น19.90 B34.96%
2018-12-31โ‚น14.74 B5.55%
2017-12-31โ‚น13.96 B87.43%
2016-12-31โ‚น7.45 B-48.23%
2015-12-31โ‚น14.39 B64.26%
2014-12-31โ‚น8.76 B-30.67%
2013-12-31โ‚น12.64 B65.21%
2012-12-31โ‚น7.65 B7.86%
2011-12-31โ‚น7.09 B87.91%
2010-12-31โ‚น3.77 B61.21%
2009-12-31โ‚น2.34 B-46.24%
2008-12-31โ‚น4.35 B-7.85%
2007-12-31โ‚น4.72 B3.73%
2006-12-31โ‚น4.55 B26.44%
2005-12-31โ‚น3.60 B13%
2004-12-31โ‚น3.18 B121.79%
2003-12-31โ‚น1.43 B-4.73%
2002-12-31โ‚น1.50 B106.95%
2001-12-31โ‚น0.72 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Agenus
AGEN
โ‚น21.04 B-75.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น2.627 T 2,985.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น11.653 T 13,586.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น5.265 T 6,084.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น10.296 T 11,992.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
โ‚น7.418 T 8,612.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚น18.777 T 21,952.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น3.585 T 4,110.86%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚น8.109 T 9,423.55%๐Ÿ‡บ๐Ÿ‡ธ USA